Recent Development Applications of Nanotechnology in Cancer: A Literature Review

P. Selvakumari¹

Section:Review Paper, Product Type: Isroset-Journal
Vol.6 , Issue.6 , pp.166-173, Dec-2018

CrossRef-DOI:   https://doi.org/10.26438/ijsrpas/v6i6.166173

Online published on Dec 31, 2018

Copyright © P. Selvakumari . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

681 Views    263 Downloads    162 Downloads

Abstract :
Oral health could be maintained by application of this technology in prevention, diagnosis and treatment. Oral cancer is a debilitating disease, and numerous research activities are being pursued worldwide to combat this deleterious process. Nanotechnology is very diverse field that has revolutionized the industry and is setting new trends in the management of oral cancer. Hence, we performed a PubMed search on nanotechnology in oral cancer and found 211 articles related to this search. We have reviewed the reported literature to the best of our abilities and summarized the various aspects of nanotechnology, its role in diagnosis - nanodiagnostics and treatment of oral cancer - nanotherapeutics in this article. Nanotechnology for oral cancer could be a use full tool for detection and drug therapy. By Possessing unprecedented potential for early stage detection, treatment of oral cancer, nanoparticles have been demonstrated over the last decade. In this review, we will summarize the current state-of-the-art of nanoparticles in biomedical applications such as detection, diagnosis and targeting over the oral cancer. Gold nanospheres, nanorods, nanoshells, nanocages, and surface enhanced nanoparticles will be discussed in detail regarding their uses in vivo imaging, cancer therapy, and drug delivery. The key feature of nanoparticle-based drug agents to target over ligands, therapeutic drugs, and other functionalities can all be integrated to allow for targeted molecular imaging and molecular therapy of oral cancer. The future of the nanotechnology for oral cancer looks brighter than ever yet many hurdles remain to be conquered. A multifunctional platform based on gold nanoparticles, with multiple receptor targeting, multimodality imaging, and multiple therapeutic entities, holds the promise for a “magic gold bullet” against oral cancer.

Key-Words / Index Term :
Diagnosis, nanotechnology, oral cancer, therapy

References :
[1] Capilla MV, Olid MNR, Gaya MVO, Botella CR, Ruiz VB. Factors related to survival from oral cancer in an Andalusian population sample. Med Oral Pathol Oral Cir Bucal 2007; 12(7):518-23.
[2] Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral Dis 2000; 6(2):65-74
[3] Chen PH, Shieh TY, Ho PS, Tsai CC, Yang YH, Lin YC, et al. Prognostic factor associated with the survival of oral and pharyngeal carcinoma in Taiwan. BMC Cancer 2007; 7:101.
[4]González AP, López MA, Martínez LV. Comportamiento clínico y epidemiológico del cáncer de cavidad oral. Hospital Oncológico Provincial Docente María Curie. Instituto Superior de Ciencias Médicas Dr. Carlos Juan Finlay; 2005.
[5] Kingsley K, O‟Malley S, Ditmyer M, Chino M. Analysis of oral cancer epidemiology in the US reveals state-specific trends: implication for oral cancer prevention. BCM Public Health 2008; 8:87.
[6] Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37:1-10.
[7] Cho WSC. Contribution of oncoproteomics to cancer 2. biomarker discovery. Mol Cancer 2007; 6 : 25.
[8] J. K. Elango, P. Gangadharan, S. Sumithra, and M. A. Kuriakose, “Trends of head and neck cancers in urban and rural India,” Asian Pacific Journal of Cancer Prevention, vol. 7, no. 1, pp. 2006; 108–112.
[9] R. Sankaranarayanan, K. Ramadas, G. Thomas et al., “Effect of screening on oral cancer mortality in Kerala, India: a clusterrandomised controlled trial,” The Lancet, vol. 365, no. 9475, pp. 1927–1933, 2005.
[10] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v 2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.
[11] National Institutes of Health Updated October 2010.
[12] Logothetidis S. Nanotechnology in medicine: the medicine of tomorrow and nanomedicine. Hippokratia 2006; 10: 7-21.
[13] Bonoiu A, Mahajan SD, Ye L, Kumar R, Ding H, Yong K-T, et al. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Research. 2009; 1282: 142-55.
[14] Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications. Nano Letters. 2010; 10: 3223-30.
[15] Karnik R, Gu F, Basto P, Cannizzaro C, Dean L, Kyei-Manu W, et al. Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles. Nano Letters. 2008; 8: 2906-12.
[16] Joseph K, Robert L. Responsive polymeric delivery systems. Advanced Drug Delivery Reviews. 2001;6: 19-50.
[17]Alexis F, Rhee J-W, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urologic Oncology: Seminars and Original Investigations. 2008;26: 74-85.
[18] Howarth M, Takao K, Hayashi Y, Ting A.Y. Targeting the quantum dots to the surface proteins in living cells with biotin ligases. Proc. Natl. Acad. Sci. USA 2005; 102: 7583-88.
[19]Chen, Y., Lian, G., Liao, C., Wang, W., Zeng, L., Qian, C., . . . Shuai, X. (2013). Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION). Journal of Gastroenterology, 48(7), 809-821. doi: 10.1007/s005350120713x 10.1016/j.jconrel.2006.05.023)Google
[20] Cheng, Z., Elias, D. R., Kamat, N. P., Johnston, E. D., Poloukhtine, A., Popik, V., . . . Tsourkas, A. (2011). Improved tumor targeting of polymer-based nanovesicles using polymer-lipid blends. Bioconjug Chem, 22(10), 2021-2029. doi: 10.1021/bc200214g
[21] Chetan C. Anajwala, G. K. J., S.M. Vijayendra Swamy. (2010). Current Trends of Nanotechnology for Cancer Therapy. International Journal of Pharmaceutical Sciences and Nanotechnology, 3(3), 1043-1056.
[22] Choi, Y. E., Kwak, J. W., & Park, J. W. (2010). Nanotechnology for early cancer detection. Sensors (Basel), 10(1), 428-455. doi: 10.3390/s100100428
[23] Cridge, B. J., Larsen, L., & Rosengren, R. J. (2013). Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers. Oncology Discovery, 1(1), 6. doi: 10.7243/2052-6199-1-6.
[24] Yan, J., Zheng, X., Liu, Z., Yu, J., Deng, Z., Xue, F., . . . Li, G. (2016). A multicenter study of using carbon nanoparticles to show sentinel lymph nodes in early gastric cancer. Surg Endosc, 30(4), 1294-1300. doi: 10.1007/s00464-015-4358-8
[25] Ye, M. X., Li, Y., Yin, H., & Zhang, J. (2012). Curcumin: updated molecular mechanisms and intervention targets in human lung cancer. Int J Mol Sci, 13(3), 3959-3978. doi: 10.3390/ijms13033959
[26] Ying Wu, W. W., Yinting Chen, Kaihong Huang, Xintao Shuai, Qikui Chen, Xuexian Li, Guoda Lian. (2010). The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro. Int J Nanomedicine, 5, 129-136.
[27] Yun-Peng Zhang, P. S., Xu-Rui Zhang, Wu-Li Yang and Cheng-Shuai Si. (2013). Synthesis of CdTe quantum dot-conjugated CC49 and their application for in vitro imaging of gastric adenocarcinoma cells. Nanoscale Res Lett, 8.
[28] Zhang, W., Zhang, Z., & Zhang, Y. (2011). The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett, 6, 555. doi: 10.1186/1556-276X6-555
[29] Zhang, Z., Niu, B., Chen, J., He, X., Bao, X., Zhu, J., . . . Li, Y. (2014). The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer. Biomaterials, 35(15), 4565-4572. doi: 10.1016/j.biomaterials.2014.02.024.
[30] Thakor, A. S., & Gambhir, S. S. (2013). Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin, 63(6), 395-418. doi: 10.3322/caac.21199
[31] Thomas, D. G., Pappu, R. V., & Baker, N. A. (2011). NanoParticle Ontology for cancer nanotechnology research. J Biomed Inform, 44(1), 59-74. doi: 10.1016/j.jbi.2010.03.001
[32] Tokuhara, T., Tanigawa, N., Matsuki, M., Nomura, E., Mabuchi, H., Lee, S. W., . . . Narabayashi, I. (2008). Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer, 11(4), 194-200. doi: 10.1007/s10120-008-0480-9
[33] Trickler, W. J., Khurana, J., Nagvekar, A. A., & Dash, A. K. (2010). Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. AAPS PharmSciTech, 11(1), 392-401. doi: 10.1208/s12249- 010-9393-0
[34] Veiseh, O., Kievit, F. M., Ellenbogen, R. G., & Zhang, M. (2011). Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliv Rev, 63(8), 582-596. doi: 10.1016/j.addr.2011.01.010
[35] Vergaro, V., Scarlino, F., Bellomo, C., Rinaldi, R., Vergara, D., Maffia, M., . . . Leporatti, S. (2011). Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells. Adv Drug Deliv Rev, 63(9), 847-864. doi: 10.1016/j.addr.2011.05.007
[36] Vladimir N. Anisimov, I. A. V., Andrei V. Panchenko1, Irina G. Popovich and, & Zabezhinski, M. A. (2012). Light-at-Night-Induced Circadian Disruption, Cancer and Aging Current Aging Science, 5, 170-177.
[37] Wang, J. J., Zeng, Z. W., Xiao, R. Z., Xie, T., Zhou, G. L., Zhan, X. R., & Wang, S. L. (2011). Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine, 6, 765-774. doi: 10.2147/IJN.S17296.